Abbott Laboratories announced a 6.8% increase to its quarterly dividend on Friday, marking the healthcare giant’s 54th consecutive year of dividend growth — a remarkable streak that places it among the most reliable dividend payers in American business.
The company’s board approved a new quarterly payout of 63 cents per share, up from the previous 59 cents, as part of a dividend program that dates back nearly a century. This increase pushes Abbott’s annual dividend to $2.52 per share and continues a pattern of significant shareholder returns that has seen the quarterly payout jump more than 70% since 2020 alone, according to company statements.
Dividend Aristocrat Status Reinforced
The dividend hike represents the 408th consecutive quarterly dividend paid by Abbott since 1924 — an extraordinary run spanning a century of economic cycles, world wars, and technological revolutions. Few companies can claim such consistency in returning capital to shareholders. The healthcare leader has maintained its position among the elite “Dividend Aristocrats” — companies in the S&P 500 that have increased dividends for at least 25 consecutive years.
What makes Abbott’s dividend growth particularly notable? Despite global economic uncertainties, the company continues to demonstrate confidence in its cash flow and business model. With a payout ratio of approximately 28.93% as reported before this increase, Abbott maintains significant flexibility for future dividend growth while investing in research and development.
“This dividend increase reflects the strength and consistency of Abbott’s cash flow and our commitment to returning value to shareholders,” the company said in its announcement.
Global Healthcare Powerhouse
Abbott, headquartered in Abbott Park, Illinois, has evolved into a diversified healthcare behemoth with 114,000 colleagues serving people in more than 160 countries worldwide. The company’s portfolio spans diagnostics, medical devices, nutritionals, and branded generic medicines — a diversification strategy that has helped Abbott weather market fluctuations and economic downturns over the decades.
The dividend news comes as Abbott continues to build on its position across multiple healthcare segments. The company’s shares have risen approximately 11% year-to-date, outperforming the broader market amid ongoing healthcare sector challenges.
Still, Abbott faces the same headwinds confronting many healthcare companies, including pricing pressures, evolving regulatory landscapes, and the need to continuously innovate. Its dividend history suggests management’s long-term confidence in navigating these challenges.
The increased dividend will be payable on February 15, 2025, to shareholders of record at the close of business on January 15, 2025, according to the company’s announcement.
For long-term investors seeking stability in uncertain markets, Abbott’s 54-year dividend growth streak represents the kind of consistency that has become increasingly rare in today’s fast-changing business environment.
